Not currently recruiting at University of California Health
Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
- Principal Investigator
- by Robert Cameron, MD (ucla)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Robert Cameron, MD (ucla)
Professor of Clinical, Surgery, Medicine. Authored (or co-authored) 55 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Ikena Oncology
- ID
- NCT05228015
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 198 study participants
- Last Updated